Christopher Smith, Ph.D. Email & Phone Number

Washington, Dc, Us

Owings Mills, Maryland, United States

- Principal Investigator - CellRADx, Point-of-Care Biodosimetry Program- Scientific Advisor - CytoRADx, High-throughput Biodosimetry Program

Owings Mills, Maryland

- Validation, Design & Development Lead - CytoRADx, High-throughput Biodosimetry Program- Technical Lead - CellRADx, Point-of-Care Biodosimetry Program

Maryland, United States

Technical Consulting-Business development. Grant and contract proposal writing for private and federal agency funding -Product development and regulatory strategy for diagnostic medical devices-Quality system optimization for medical device companies-Artificial Intelligence implementation strategy for biotechnology and pharmaceutical companies Philanthropy-Educational presentations and videos on science concepts-Science and career fairs

Gaithersburg, Maryland

Assay Development and Assay Services Departments-Spearheaded development and commercialization of biomarker assays for numerous indications-Designed and optimized immunoassays for targets related to biodosimetry, cardiovascular disease, immunology, metabolism, neurobiology, oncology, and toxicology-Developed assays in collaboration with nonprofit organizations, KOLs from academic medical centers, and pharmaceutical partners-Validated assays internally and externally, across laboratories and organizations-Fostered relationships and managed contributions of stakeholders across internal departments, including Marketing and Quality Assurance-Drafted customer-facing scientific communications, e.g. package inserts, posters, and presentations, for marketing and training on the uses, benefits, and capabilities of company products-Implemented unique approaches to drastically reduce the time required to launch new products

Baltimore, Md

Department of Neurology & NeurosurgeryAlfredo Quiñones-Hinojosa Lab-Developed institutional review board-approved protocols that employed donated patient samples and clinical data to study state-of-the-art diagnostic tools and treatment methods for brain cancer-Collaborated with physician scientists in oncology to investigate new drug targets, e.g. proton exchanger NHE9 and glycogenolytic enzyme G6CP, implicated in cancer metabolism and invasion-Engineered cell-based approaches for delivery of therapeutic proteins, e.g. BMP4, to tumors-Delivered numerous presentations on cutting edge research to patients, physicians, and fellow scientists-Mentored 3 undergraduate students, who have advanced to graduate careers in medicine and scientific research. Trained numerous researchers, at various career levels, in nanotechnology-Research partnership generated six publications and over $500K in additional grants and awards

Baltimore, Md

Department of Biomedical EngineeringAndre Levchenko LabDepartment of NeurosurgeryAlfredo Quiñones-Hinojosa Lab (co-adviser)-Initiated NIH R01 grant-awarded partnership with opinion-leading neurosurgeons and oncologists to study brain cancer, specifically glioblastoma, and modern therapeutic techniques-Coordinated joint meetings, experimental efforts, and interdisciplinary training across partner labs-Studied the effects of growth factor signaling, e.g. PDGF, ion transport through NKCC1, and mechanical cues from the tumor microenvironment on cancer cell motility and invasiveness-Designed and utilized novel micro- and nanotechnological tools to study cell behaviors, e.g. migration, adhesion, intercellular signaling, and signal transduction, in unprecedented ways-Developed diagnostic device to predict clinical outcomes, e.g. tumor recurrence and location, based on cell migratory responses to mechanical and biochemical cues, as well as receptor expression

Artificial Intelligence In Pharma And Biotech

Ph.D., Biomedical Engineering

Bachelor Of Science, Chemical-Biological Engineering